Table 2 Comparison of HIV and HCV prevalence (2004/2005) and the trends in newly diagnosed HIV infections (2004 to 2011) in surveillance data*, in Poland by region
Source of information | Indicator | Region | |||||
|---|---|---|---|---|---|---|---|
Lubelskie | Lubuskie | Śląskie | Warmińsko-mazurskie | Mazowieckie | Dolnośląskie | ||
Region total population (2012, Central Statistics Office) | 2165651 | 1023317 | 4615870 | 1450697 | 5301760 | 2914362 | |
Bio-behavioural study | HIV prevalence (%) | 28.7 | 9.0 | 13.3 | 2.4 | 16.0 | 31.5 |
HCV prevalence (%) | 43.7 | 55.1 | 68.3 | 59.8 | 60.0 | 64.0 | |
In at least one site in the region the HCV prevalence was >50% and HIV prevalence was <5% | No | Yes | No | Yes | No | No | |
In at least one site in the region there was no needle/syringe programme in the city | Yes | Yes | Yes | No | No | No | |
Proportion of short-term injectors (≤5 years, %) | 26.7 | 57.1 | 38.3 | 55.4 | 62.7 | 33.5 | |
Proportion current (past 30 days) opioid users (%) | 48.3 | 69.2 | 75.0 | 54.9 | 90 | 83.7 | |
Proportion sharing needles/syringes (past 12 months, %) | 19.4 | 26.9 | 28.3 | 29.3 | 25.8 | 27.8 | |
Case-based surveillance | Estimated number of new HIV diagnoses in 2004 (95% CI)* | 6 (1–10) | 9 (2–17) | 43 (35–52) | 20 (17–24) | 39 (17–61) | 90 (77–103) |
Peak year in 2000 to 2012; number during the peak year* | 2000; 15 | 2009; 18 | 2001; 55 | 2000; 41 | 2007; 58 | 2003; 107 | |
Diagnosis rate ratios**: | |||||||
2004 to 2005 (cross-sectional study period) | ref. | ref. | ref. | ref. | ref. | ref. | |
2008 to 2009 | 0.7 (0.3-1.8) | 1.6 (0.9-2.9) | 0.4 (0.3-0.6) | 0.7 (0.4-1.1) | 1 (0.8-1.4) | 0,7 (0,5-0,9) | |
2010 to 2011 | 0.5 (0.2-1.5) | 0.7 (0.4-1.5) | 0.6 (0.4-0.8) | 0.5 (0.3-0.8) | 0.5 (0.4-0.8) | 0,5 (0,4-0,6) | |